- Home
- AGNC vs QGEN Comparison
AGNC vs QGEN Comparison
Compare AGNC & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- QGEN
- Stock Information
- Founded
- AGNC 2008
- QGEN 1986
- Country
- AGNC United States
- QGEN Netherlands
- Employees
- AGNC N/A
- QGEN N/A
- Industry
- AGNC Real Estate Investment Trusts
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGNC Real Estate
- QGEN Health Care
- Exchange
- AGNC Nasdaq
- QGEN Nasdaq
- Market Cap
- AGNC 9.2B
- QGEN 10.3B
- IPO Year
- AGNC 2008
- QGEN 1996
- Fundamental
- Price
- AGNC $10.37
- QGEN $47.56
- Analyst Decision
- AGNC Buy
- QGEN Buy
- Analyst Count
- AGNC 8
- QGEN 8
- Target Price
- AGNC $9.63
- QGEN $51.01
- AVG Volume (30 Days)
- AGNC 17.6M
- QGEN 1.4M
- Earning Date
- AGNC 10-20-2025
- QGEN 11-05-2025
- Dividend Yield
- AGNC 13.88%
- QGEN 3.18%
- EPS Growth
- AGNC N/A
- QGEN 405.09
- EPS
- AGNC 0.26
- QGEN 1.69
- Revenue
- AGNC $496,000,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- AGNC $9.87
- QGEN $7.22
- Revenue Next Year
- AGNC $58.56
- QGEN $5.66
- P/E Ratio
- AGNC $40.31
- QGEN $27.78
- Revenue Growth
- AGNC N/A
- QGEN 5.15
- 52 Week Low
- AGNC $7.85
- QGEN $37.63
- 52 Week High
- AGNC $10.85
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- AGNC 75.96
- QGEN 45.68
- Support Level
- AGNC $9.62
- QGEN $46.27
- Resistance Level
- AGNC $9.86
- QGEN $47.38
- Average True Range (ATR)
- AGNC 0.13
- QGEN 0.71
- MACD
- AGNC 0.05
- QGEN -0.20
- Stochastic Oscillator
- AGNC 98.77
- QGEN 42.05
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).